Bipolar Disorders

Valbenazine significantly reduced involuntary movements associated with tardive dyskinesia in patients with primary mood disorders, at both 6 weeks and 48 weeks after beginning the treatment, according to a published analysis.

Articles

ORLANDO, Fla.—Mental health clinicians should avoid antidepressants in patients with depressive symptoms that coexist with symptoms of mania, Joseph F. Goldberg, MD, advised attendees at Psych Congress 2018.

ORLANDO, Fla.—The atypical antipsychotic cariprazine outperformed placebo in reducing depressive symptoms in patients with bipolar I disorder, according to a poster presented at Psych Congress 2018.

People with depression or bipolar disorder were found to have a larger hypothalamus, compared with healthy control subjects, in a study published in Acta Psychiatrica Scandinavia.

Researchers have developed a small, low-cost cotton sensor that can effectively monitor a range of lithium levels in patients prescribed the drug.

VNS

Patients with treatment-resistant depression who received adjunctive vagus nerve stimulation experienced a significant improvement in quality of life even when their depression failed to ease enough to qualify as a clinical response.

Pages

Blogs

To have experienced delusions, psychosis, and suicidal ideation is to be Undermined by one’s self.

Although the diagnostic criteria for the two conditions seem distinctive at first glance, there is a significant degree of variability of symptom presentation.

Help me to let go and Live, to bloom in resonance with the rest of our passionate universe. To see my own life as something sacred and not just a death sentence to serve until it is finally over.

Pages

Posters

Jessica Madera, MD; Na Jin, MS; Pedro Such, MD; Brian Johnson, MS; Ross A. Baker, PhD
Joseph McEvoy, MD; Benjamin Carroll, PharmD; Sanjay Gandhi, PhD; Avery Rizio, PhD; Stephen Maher, PhD; Mark Kosinski, MA; Jakob Bjorner, MD, PhD
Stewart Factor, DO; Karen Anderson, MD; Mat Davis, PhD; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Hubert Fernandez, MD
Karen Anderson, MD; Mat Davis, PhD; Stewart Factor, DO; Robert Hauser, MD, MBA; Lars Jarskog, MD; Joohi Jimenez-Shahed, MD; Rajeev Kumar, MD, FRCPC; Stanislaw Ochudlo, MD, PhD; William Ondo, MD; Hubert Fernandez, MD
Joseph R. Calabrese, MD; Raymond Sanchez, MD; Na Jin, MS; Joan Amatniek, MD; Kevin Cox, MD; Brian Johnson, MS; Peter Hertel, PhD; Pedro Such, MD; Margaretta Nyilas, MD; William H. Carson, MD

Pages

Video

Psych Congress Steering Committee members Vladimir Maletic, MD, MS, and Jon W. Draud, MD, MS, discuss the clinical consequences of misdiagnosing mixed mood states.

Terence Ketter, MD, Professor of Psychiatry at Stanford University in Stanford, California, discusses how often first-line treatments for bipolar disorder have inadequate outcomes.

Psych Congress Steering Committee members Vladimir Maletic, MD, MS, and Jon W. Draud, MD, MS, discuss established and emerging treatment options for patients with mixed mood states.

Pages